Fatal Hepatorenal Failure Associated with Hydrazine Sulfate
- 5 December 2000
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 133 (11) , 877-880
- https://doi.org/10.7326/0003-4819-133-11-200012050-00011
Abstract
The Internet has revolutionized the manner in which patients obtain information about health care. This technology has also allowed patients to obtain directly both prescription and nonprescription therapies. To report a case of fulminant hepatorenal failure associated with the use of hydrazine sulfate, an unregulated alternative remedy for cancer marketed on the Internet. Case report. Academic medical center. A 55-year-old man with maxillary sinus cancer. Self-medication with hydrazine sulfate. Serum liver and renal function tests; histologic evaluation of liver and kidney tissue. The patient developed hepatic encephalopathy, renal failure, and profound coagulopathy. He died after severe gastrointestinal hemorrhage developed. Autopsy revealed autolysis of the kidneys and submassive bridging necrosis of the liver. Fatal hepatorenal failure may occur after the use of hydrazine sulfate. This fatal complication must be considered in anyone taking or contemplating the use of hydrazine sulfate.Keywords
This publication has 7 references indexed in Scilit:
- Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national surveyComplementary Therapies in Medicine, 1999
- Biology of CachexiaJNCI Journal of the National Cancer Institute, 1997
- Drug-Induced HepatotoxicityPublished by Springer Nature ,1996
- Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.Journal of Clinical Oncology, 1990
- Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experienceCancer, 1987
- Hydrazine sulfate: A current perspectiveNutrition and Cancer, 1987
- Use of Hydrazine Sulfate in Terminal and Preterminal Cancer Patients: Results of Investigational New Drug (IND) Study in 84 Evaluable PatientsOncology, 1975